4.7 Article

LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma

Wenjun Yu et al.

Summary: This study validated the higher expression of YAP in lung adenocarcinoma (LUAD) tissues and revealed the regulatory mechanism of YAP mRNA stability. The study also found that YAP m(5)C modification enhanced exosome secretion, contributing to the malignant phenotype and drug resistance of LUAD cells.

CANCER GENE THERAPY (2023)

Review Oncology

The interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer

Wentao Zeng et al.

Summary: Oncogene-induced hyper-proliferation in cancer cells leads to different stresses, including DNA-replication stress, metabolic stress, and oxidative stress. The excessive accumulation of reactive oxygen species (ROS) plays a crucial role in tumor progression by influencing cell signaling pathways. Cancer cells also rely on oxidative stress and increased iron demands to affect ferroptosis sensitivity. Targeting redox homeostasis and ferroptosis has become a promising approach to overcome drug resistance in cancer treatment. This review summarizes the current understanding of the interplay between redox regulation, ferroptosis, and oncogenic signaling in cancer biology, and discusses strategies for targeting oxidative stress and ferroptosis in cancer treatment.

INTERNATIONAL JOURNAL OF CANCER (2023)

Review Biochemistry & Molecular Biology

Ferroptosis in cancer therapy: a novel approach to reversing drug resistance

Chen Zhang et al.

Summary: Ferroptosis, an iron-dependent form of cell death, plays a crucial role in tumor suppression and has the potential to reverse cancer therapy resistance.

MOLECULAR CANCER (2022)

Article Oncology

EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma

Adam D. Durbin et al.

Summary: Gene expression is regulated by histone modifications, and EP300 plays a significant role in high-risk neuroblastoma. The compound JQAD1, which targets EP300, effectively induces cell apoptosis in neuroblastoma cells with limited toxicity to normal cells.

CANCER DISCOVERY (2022)

Article Oncology

Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma

Xiao Zhang et al.

Summary: This study found that plasma exosomes from LUAD patients can reduce lipid peroxidation and desensitize LUAD cells to ferroptosis. The exosomal circRNA_101093 (cir93) interacted with fatty acid-binding protein 3 (FABP3) to modulate the peroxidation reactions critical for ferroptosis. Blocking exosomes may be helpful for future LUAD treatment.

CANCER COMMUNICATIONS (2022)

Article Dermatology

CAMKK2 Defines Ferroptosis Sensitivity of Melanoma Cells by Regulating AMPK-NRF2 Pathway

Sijia Wang et al.

Summary: CAMKK2 regulates the sensitivity of melanoma cells to ferroptosis by modulating the AMPK.NRF2 pathway, potentially playing a crucial role in melanoma treatment.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Oncology

Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031

Jessica A. Pollard et al.

Summary: The study investigated the feasibility and efficacy of adding sorafenib, a multikinase tyrosine kinase inhibitor, to standard chemotherapy and as single-agent maintenance therapy in pediatric acute myeloid leukemia (AML) with high allelic ratio (HAR) FLT3/ITD mutations. The results showed that sorafenib can be safely added to conventional AML chemotherapy and may improve outcomes in this population. Patients treated with sorafenib had higher survival rates and disease-free survival rates compared to those who did not receive sorafenib.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis

Alex Reed et al.

Summary: The discovery of potent inhibitors of LPCAT3 provides a new tool to study the biological processes involving LPCAT3 and its potential role in ferroptosis. The inhibitors cause rapid rewiring of polyunsaturated phospholipids in human cells, which may explain the partial protection from ferroptosis observed in cells with LPCAT3 disruption.

ACS CHEMICAL BIOLOGY (2022)

Article Developmental Biology

The unfolding of the Hippo signaling pathway

Duojia Pan

Summary: This article reviews the early discoveries about the Hippo signaling pathway, highlighting its significance in the regulation of organ size and emphasizing the value of model organisms in uncovering mechanisms of life processes.

DEVELOPMENTAL BIOLOGY (2022)

Article Genetics & Heredity

Histone editing elucidates the functional roles of H3K27 methylation and acetylation in mammals

Aditya Sankar et al.

Summary: This study investigated the regulatory role of histone H3 modifications on gene expression using CRISPR base editing in mouse embryonic stem cells. The results showed that H3K27 is an essential substrate for PRC2, while other modifications besides H3K27 acetylation may be involved in mediating CBP/EP300 function.

NATURE GENETICS (2022)

Article Cell Biology

ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression

Julia Grube et al.

Summary: This study finds that ferroptotic cell death is not an endogenous tumor-suppressive mechanism during HCC formation, but instead has an unanticipated cancer-promoting effect due to aggravated liver damage, suggesting that ferroptosis may have both cancer-promoting and cancer-inhibitory effects during HCC progression and therapy.

CELL DEATH & DISEASE (2022)

Article Biochemistry & Molecular Biology

The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy

Lu Liang et al.

Summary: Researchers have developed novel biomimetic nanoparticles activated by matrix metalloproteinase 2 (MMP2) to effectively deliver miRNA to lung cancer cells. These nanoparticles, camouflaged with red blood cell (RBC) membranes, have the advantages of extended circulation time, lower toxicity, better biocompatibility, and immune escape. In vitro and in vivo experiments have demonstrated the ability of these nanoparticles to induce apoptosis in lung cancer cells and inhibit the development and progression of lung adenocarcinoma by targeting ADAM9.

MOLECULAR CANCER (2022)

Article Biochemistry & Molecular Biology

The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing

Chengdi Wang et al.

Summary: An investigation into the immune landscape is crucial for immunotherapy strategies and predicting clinical responses in non-small-cell lung cancer patients. Using single-cell RNA sequencing, researchers have identified immune signature differences between lung adenocarcinoma and lung squamous cell carcinoma, the two major subtypes of NSCLC. They found that cytotoxic and effector T and NK cells, as well as distinct macrophage subtypes, play central roles in the immune microenvironment heterogeneity between the two subtypes. This comprehensive depiction of immune heterogeneity could aid in personalized treatment design.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Medicine, Research & Experimental

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis

Ruize Gao et al.

Summary: The study reveals the critical role of YAP/TAZ in suppressing ferroptosis and establishing Sorafenib resistance in hepatocellular carcinoma (HCC). This highlights YAP/TAZ-based rewiring strategies as potential approaches to overcome HCC therapy resistance. The findings provide new insights into improving the efficacy of current therapies in cancer treatment.

EMBO MOLECULAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose

You Wu et al.

Summary: This study demonstrated that HMGB1 regulates glucose-induced ferroptosis via Nrf2 pathway in mesangial cells, suggesting its therapeutic potential in diabetic kidney disease.

BIOSCIENCE REPORTS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2

Wen-Hsuan Yang et al.

Summary: The study reveals that YAP promotes ferroptosis by regulating SKP2, suggesting novel therapeutic options for YAP-driven tumors.

MOLECULAR CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

Phospholipase iPLA2β averts ferroptosis by eliminating a redox lipid death signal

Wan-Yang Sun et al.

Summary: By hydrolyzing 15-HpETE-PE, iPLA(2)beta prevents ferroptosis, while its dysfunction increases cellular sensitivity to ferroptosis. Mutations in PLA2G6 gene may be implicated in the pathogenesis of Parkinson's disease.

NATURE CHEMICAL BIOLOGY (2021)

Article Cell Biology

Oncogenic Activation of YAP Signaling Sensitizes Ferroptosis of Hepatocellular Carcinoma via ALOXE3-Mediated Lipid Peroxidation Accumulation

Yifei Qin et al.

Summary: YAP signaling plays a crucial role in regulating ferroptotic cell death, with its activation significantly increasing sensitivity of hepatocellular carcinoma cells to ferroptosis. Furthermore, the study found that YAP promotes ferroptosis through targeting the gene ALOXE3. Therefore, pathogenic alterations in the YAP signaling pathway may serve as biomarkers to predict cancer cell responsiveness to future ferroptosis-inducing therapies.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Cell Biology

Transcriptional Repression of Ferritin Light Chain Increases Ferroptosis Sensitivity in Lung Adenocarcinoma

Yikun Wang et al.

Summary: The study suggests that suppressing FTL transcription through inhibiting the YAP-TFCP2-KAT5 complex could be another mechanism to increase ferroptosis sensitivity and induce cell death. Lower levels of lipid peroxidation in LUAD patients may lead to better results with ferroptotic therapy.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Cell Biology

GSK-3β manipulates ferroptosis sensitivity by dominating iron homeostasis

Lingjuan Wang et al.

Summary: Ferroptosis is a newly characterized form of non-apoptotic-programmed cell death that has implications in human diseases and potential therapeutic applications for cancer. GSK-3 beta acts as a positive modulator of ferroptosis by influencing cellular iron metabolism, indicating its potential as a target for cancer chemotherapy.

CELL DEATH DISCOVERY (2021)

Article Oncology

CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma

Zhixian Wang et al.

Summary: In this study, it was found that CREB is highly expressed in LUAD and can promote cell death by inhibiting lipid peroxidation, with close association with GPX4 and EP300. Targeting the CREB/EP300/GPX4 axis may provide new strategies for treating LUAD, especially in tumors with higher malignancy.

ONCOLOGY REPORTS (2021)

Article Cell Biology

O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer

Guoqing Zhu et al.

Summary: This study found that O-GlcNAcylation increases the sensitivity of HCC cells to ferroptosis through YAP/TFRC. This discovery provides a new basis for clinical therapeutic strategies for HCC patients.

CELL DEATH DISCOVERY (2021)

Article Gastroenterology & Hepatology

Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling

Cindy Lobe et al.

Summary: The transcription factor ZEB1 plays a crucial role in the progression of cholangiocarcinoma by regulating the crosstalk between tumor cells and cancer-associated fibroblasts (CAFs), leading to tumor dedifferentiation and CAF activation. In vitro and in vivo experiments demonstrated that ZEB1 promotes epithelial-mesenchymal transition and stemness in tumor cells, as well as inducing myofibroblast proliferation through the upregulation of connective tissue growth factor (CTGF). The study also found that ZEB1 controls the expression of paracrine signals such as HGF and IL6 in both tumor cells and myofibroblasts.

HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

OGT regulated O-GlcNAcylation promotes papillary thyroid cancer malignancy via activating YAP

Xiaoyan Li et al.

Summary: The incidence of thyroid cancer is increasing globally, with poor prognosis associated with distant metastases. OGT and YAP play critical roles in papillary thyroid cancer, suggesting potential for targeted therapies.

ONCOGENE (2021)

Article Genetics & Heredity

Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis

Ziyuan Ren et al.

Summary: This study established a 15-gene prognostic signature based on ferroptosis-related genes for lung adenocarcinoma (LUAD) and validated its predictive ability, providing nomograms for clinical reference. Functional analysis revealed associations between ferroptosis and cell cycle, cell metabolism, and immune pathways. Pan-cancer analysis demonstrated the heterogeneity of these genes among different cancer types. Ten genes were identified as potential targets for further research, with KRAS and PGD suggested as novel immunotherapy biomarkers.

FRONTIERS IN GENETICS (2021)

Article Biochemistry & Molecular Biology

Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

Simon J. Hogg et al.

Summary: The study found that catalytic inhibition of P300/CBP dynamically disrupts steady-state acetylation kinetics and suppresses oncogenic transcriptional networks without changing chromatin accessibility. CRISPR-Cas9 screening identified NCOR1 and HDAC3 as the key antagonists of P300/CBP by counteracting acetylation turnover kinetics. Deacetylation of H3K27 provides nucleation sites for reciprocal methylation switching, which can be therapeutically exploited by simultaneous KDM6A and P300/CBP inhibition.

MOLECULAR CELL (2021)

Article Medicine, Research & Experimental

Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma

Xiao Zhang et al.

Summary: Endogenous glutamate accumulation determines ferroptosis sensitivity by suppressing YAP in LUAD cells in response to system X-C- inhibition. ADCY10 acts as a key downstream target, affecting the PKA-dependent suppression of GFPT1 by glutamate. High ADCY10 expression in advanced-stage LUAD leads to increased sensitivity to ferroptosis, especially in therapy-resistant tumors.

THERANOSTICS (2021)

Article Medicine, Research & Experimental

ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM

Yanming Zhou et al.

Summary: Research revealed that ZEB1 can promote the development and metastasis of HCC by transcriptionally upregulating the muscle isoform of phosphofructokinase-1 (PFKM). The transcriptional activity of ZEB1 on PFKM is crucial, suggesting that inhibition of ZEB1 towards PFKM may serve as a potential therapeutic strategy for HCC.

THERANOSTICS (2021)

Article Biochemistry & Molecular Biology

CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer

Haiyang Zhang et al.

MOLECULAR CANCER (2020)

Article Biochemistry & Molecular Biology

Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer

Nora Feldker et al.

EMBO JOURNAL (2020)

Review Oncology

Targeting Ferroptosis to Iron Out Cancer

Behrouz Hassannia et al.

CANCER CELL (2019)

Article Biochemistry & Molecular Biology

Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming

Ayyub Ebrahimi et al.

NATURE CHEMICAL BIOLOGY (2019)

Article Multidisciplinary Sciences

Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis

Masahiro Yoshida et al.

NATURE COMMUNICATIONS (2019)

Article Chemistry, Multidisciplinary

Recent Progress in Ferroptosis Inducers for Cancer Therapy

Chen Liang et al.

ADVANCED MATERIALS (2019)

Article Biochemistry & Molecular Biology

Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism

Hiroshi Kuwata et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)

Review Cell Biology

Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine

Ivan M. Moya et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Article Cell Biology

ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM

Xiang Zhang et al.

CELL DEATH & DISEASE (2018)

Article Biochemistry & Molecular Biology

Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis

Valerian E. Kagan et al.

NATURE CHEMICAL BIOLOGY (2017)

Article Multidisciplinary Sciences

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

Matthew J. Hangauer et al.

NATURE (2017)

Article Multidisciplinary Sciences

The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis

Xiao Zhang et al.

NATURE COMMUNICATIONS (2017)

Article Cell & Tissue Engineering

An FAK-YAP-mTOR Signaling Axis Regulates Stem Cell-Based Tissue Renewal in Mice

Jimmy Kuang-Hsien Hu et al.

CELL STEM CELL (2017)

Article Biochemistry & Molecular Biology

Identification of ACSL4 as a biomarker and contributor of ferroptosis

Hua Yuan et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Review Biochemistry & Molecular Biology

Ferroptosis: process and function

Y. Xie et al.

CELL DEATH AND DIFFERENTIATION (2016)

Article Multidisciplinary Sciences

ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types

Waltraut Lehmann et al.

NATURE COMMUNICATIONS (2016)

Article Gastroenterology & Hepatology

Mutual Interaction Between YAP and CREB Promotes Tumorigenesis in Liver Cancer

Jiayi Wang et al.

HEPATOLOGY (2013)

Article Biochemistry & Molecular Biology

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon et al.